Drug-resistance gene expression and progression of astrocytic tumors
β Scribed by Satoshi Tanaka; Ikuo Kobayashi; Hidehiro Oka; Kiyotaka Fujii; Takashi Watanabe; Tadashi Nagashima; Tomokatsu Hori
- Publisher
- Springer Japan
- Year
- 2001
- Tongue
- English
- Weight
- 788 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1433-7398
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recently, an enzymatic amplification method, the polymerase chain reaction (PCR), was modified to amplify a sequence of a drug resistance gene. The PCR assay can confirm data achieved by conventional molecular biology techniques, while requiring less time and fewer patient cells. It can be quantitat
## Abstract Alterations in the expression of certain genes or in their products can render benign tumor cells metastatic. Experimentally this has been quickly performed by transferring dominantly acting oncogenes such as cβHβras^EJ^ into susceptible cells, but __in vivo__ such a rapid qualitative c
## Abstract ## BACKGROUND Astrocytic tumors are the most common tumors of the central nervous system. The mechanisms of genetic change of astrocytic tumors have not been understood completely. Recently, survivin has been identified as a member of the inhibitorβofβapoptosis family. Survivin express